Share Prices & Company Research

Stockbroking

AstraZeneca

Current Price 4744.69p Bid 4752.00p Ask 4754.00p Change -0.40%
Last Updated: 24/02/2018 15:41. Prices delayed by at least 15 minutes.
Call 0113 243 6941 or search for your local office

Company Overview

AstraZeneca plc is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, Cardiovascular & Metabolic Diseases and Respiratory. The Company also is selectively active in the areas of autoimmunity, neuroscience and infection. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.

Financial Highlights Year Ended 31/12/2017

Turnover
£22,465.00m
Operating Profit
£3,677.00m
Dividend Yield
4.22
Dividend Per Share
202.50
Dividend Cover
1.17
P/E Ratio
20.25

Key Personnel

Pascal Claude Roland Soriot
Chief Executive Officer
Marc Pierre Jean Dunoyer
Chief Financial Officer
Leif Valdemar Johansson
Non-Executive Chairman
Prof Geneviève Bernadette Berger
Non-Executive Director
Graham Andrew Chipchase
Non-Executive Director
Rudolph Harold Peter Markham
Non-Executive Director
Baroness Shriti Vadera
Non-Executive Director
Marcus Wallenberg
Non-Executive Director
Sherilyn Dawn McCoy
Non-Executive Director
Deborah DiSanzo
Non-Executive Director
Philip Arthur John Broadley
Non-Executive Director
Prof Sabera Nazneen Rahman
Non-Executive Director

Stock Details

EPIC
AZN
ISIN
GB0009895292
Shares in Issue
1,266,395,869
Market cap
£60,780.67m

Analyst Views (15)

Strong Buy
 
53.33%
Buy
 
13.33%
Hold
 
26.67%
Sell
 
6.67%
Strong Sell
 
0.00%
The above information represents a selection of the views published in the last 120 days by analysts. It is subject to change without notice and doesn't reflect view held by Redmayne Bentley and is not advice.

Price Summary

Mid Price
4753.00p
Bid Price
4752.00p
Ask Price
4754.00p
Volume
1836745
Change Today
-19.00p
% Change Today
-0.40%
Open
4767.50p
Previous Close
4752.00p
Intraday High
4791.00p
Intraday Low
4710.50p
52 Week High
5520.00p
52 Week Low
4260.00p
52 week high and low figures quoted above are calculated from intraday price data.

Intra-Day Chart

AstraZeneca Intra-day Chart

AstraZeneca News

News in this section is provided by MoneyAM

AstraZeneca, Merck ovarian cancer treatment gets European nod 23 Feb 2018 | 13:07 FTSE falls flat on weaker miners 19 Feb 2018 | 11:55 UK stocks open flat as investors await key economic data 19 Feb 2018 | 09:08 AstraZeneca's Imfinzi secures FDA approval 19 Feb 2018 | 07:54 Broker Forecast - Berenberg issues a broker note on AstraZeneca PLC 08 Feb 2018 | 08:20 Broker Forecast - Kepler Cheuvreux issues a broker note on AstraZeneca PLC 06 Feb 2018 | 09:00 Director Deals - AstraZeneca PLC (AZN) 05 Feb 2018 | 14:55 Falling commodity prices hit FTSE 02 Feb 2018 | 16:53 FTSE follows US and Asia lower 02 Feb 2018 | 11:44 AstraZeneca reports Q4 product sales growth, maintains full year dividend 02 Feb 2018 | 07:42 Encouraging economic data pushes FTSE higher 26 Jan 2018 | 16:51 GDP surprise gives boost to UK-facing large caps 26 Jan 2018 | 11:42 AZ reports positive results from KRONOS trial 26 Jan 2018 | 07:38 Metal price recovery pushes FTSE higher 19 Jan 2018 | 11:49 AstraZeneca gets approvals in Japan 19 Jan 2018 | 07:26 Broker Forecast - Jefferies International issues a broker note on AstraZeneca PLC 16 Jan 2018 | 13:40 Broker Forecast - Exane BNP Paribas issues a broker note on AstraZeneca PLC 16 Jan 2018 | 10:50 Broker Forecast - Deutsche Bank issues a broker note on AstraZeneca PLC 11 Jan 2018 | 10:30 FTSE 100 follows US higher 18 Dec 2017 | 11:38 AstraZeneca lung cancer drug granted priority review in US 18 Dec 2017 | 07:13 Director Deals - AstraZeneca PLC (AZN) 15 Dec 2017 | 13:25 Broker Forecast - Deutsche Bank issues a broker note on AstraZeneca PLC 05 Dec 2017 | 10:00 FTSE falls as copper price declines 27 Nov 2017 | 16:55 FTSE rises as Glaxo gets shot in the arm 27 Nov 2017 | 11:55 AZ submits Tagrisso application in Japan 27 Nov 2017 | 07:20 Broker Forecast - HSBC issues a broker note on AstraZeneca PLC 16 Nov 2017 | 08:30 AZ Fasenra gets FDA approval for severe asthma 15 Nov 2017 | 09:35 AstraZeneca receives positive EU CHMP opinion for asthma treatment 10 Nov 2017 | 13:06 FTSE 100 dips after weak Wall Street trading 09 Nov 2017 | 08:37 AstraZeneca operating profits rise 09 Nov 2017 | 07:11

Assets (£m)

Data has been provided by MoneyAM

Reporting Date
31 Dec 2017
31 Dec 2016
Tangible Assets
7,615.0
6,848.0
Intangible Assets & Goodwill
38,013.0
39,244.0
Investments & Other Non-Current Assets
4,576.0
3,172.0
Total Non-Current Assets
50,204.0
49,264.0
Inventory
3,035.0
2,334.0
Trade & Receivables
5,009.0
4,573.0
Cash & Receivables
3,324.0
5,018.0
Other Current Assets & Assets Held for Resale
1,782.0
1,337.0
Total Assets
63,354.0
62,526.0

Liabilities (£m)

Data has been provided by MoneyAM

Reporting Date
31 Dec 2017
31 Dec 2016
Short Term Liabilities
16,383.0
15,256.0
Long Term Liabilities
30,329.0
30,601.0
Other Liabilities / Pension etc
0.0
0.0
Total Liabilities
46,712.0
45,857.0

Net Assets (£m)

Data has been provided by MoneyAM

Reporting Date
31 Dec 2017
31 Dec 2016
Net Assets
16,642.0
16,669.0

Equity (£m)

Data has been provided by MoneyAM

Reporting Date
31 Dec 2017
31 Dec 2016
Share Capital
317.0
316.0
Minority Interests
1,682.0
1,815.0
Retained Earnings
8,221.0
8,140.0
Share Premium Account
4,393.0
4,351.0
Other Equity
2,029.0
2,047.0
Total Equity
16,642.0
16,669.0

Cashflow (£m)

Data has been provided by MoneyAM

Reporting Date
31 Dec 2017
31 Dec 2016
Cashflow from Operating Activities
3,578.0
4,145.0
Cashflow Before Financing
1,250.0
176.0
Increase / Decrease in Cash
-1,686.0
-1,148.0

Income (£m)

Data has been provided by MoneyAM

Reporting Date
31 Dec 2017
31 Dec 2016
Turnover
22,465.0
23,002.0
Cost of Sales
4,318.0
4,126.0
Gross Profit
18,147.0
18,876.0
Operating Profit
3,677.0
4,902.0
Pre-Tax Profit
2,227.0
3,552.0
Profit / Loss for the Year
2,868.0
3,406.0

Dividend History

Data has been provided by MoneyAM

Period
Ex-Dividend Date
Payment Date
H2 Dividend
15 Feb 2018
19 Mar 2018
H1 Dividend
10 Aug 2017
11 Sep 2017
H2 Dividend
16 Feb 2017
20 Mar 2017
H1 Dividend
11 Aug 2016
12 Sep 2016
H2 Dividend
18 Feb 2016
21 Mar 2016
H1 Dividend
13 Aug 2015
14 Sep 2015
H2 Dividend
19 Feb 2015
23 Mar 2015
H1 Dividend
13 Aug 2014
15 Sep 2014
H2 Dividend
19 Feb 2014
24 Mar 2014
H1 Dividend
14 Aug 2013
16 Sep 2013
H2 Dividend
13 Feb 2013
18 Mar 2013
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.